Abstract:Surgical site infection (SSI) is a common type of hospital‐acquired infection and affects up to a third of patients following surgical procedures. It is associated with significant mortality and morbidity. In the United Kingdom alone, it is estimated to add another £30 million to the cost of adult cardiac surgery. Although generic guidance for SSI prevention exists, this is not specific to adult cardiac surgery. Furthermore, many of the risk factors for SSI are prevalent within the cardiac surgery population. Despite this, there is currently no standard of care for SSI prevention in adults undergoing cardiac surgery throughout the preoperative, intraoperative and postoperative periods of care, with variations in practice existing throughout from risk stratification, decontamination strategies and surveillance. Primary objective: to assess the clinical effectiveness of pre‐, intra‐, and postoperative interventions in the prevention of cardiac SSI. Secondary objectives: (i) to evaluate the effects of SSI prevention interventions on morbidity, mortality, and resource use; (ii) to evaluate the effects of SSI prevention care bundles on morbidity, mortality, and resource use. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, MEDLINE (Ovid, from inception) and Embase (Ovid, from inception) on 31 May 2021. ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) were also searched for ongoing or unpublished trials on 21 May 2021. No language restrictions were imposed. We included RCTs evaluating interventions to reduce SSI in adults (≥ 18 years of age) who have undergone any cardiac surgery. We followed the methods as per our published Cochrane protocol. Our primary outcome was surgical site infection. Our secondary outcomes were all‐cause mortality, reoperation for SSI, hospital length of stay, hospital readmissions for SSI, healthcare costs and cost‐effectiveness, quality of life (QoL), and adverse effects. We used the GRADE approach to assess the certainty of evidence. A total of 118 studies involving 51,854 participants were included. Twenty‐two interventions to reduce SSI in adults undergoing cardiac surgery were identified. The risk of bias was judged to be high in the majority of studies. There was heterogeneity in the study populations and interventions; consequently, meta‐analysis was not appropriate for many of the comparisons and these are presented as narrative summaries. We focused our reporting of findings on four comparisons deemed to be of great clinical relevance by all review authors. Decolonisation versus no decolonisation Pooled data from three studies (n = 1564) using preoperative topical oral/nasal decontamination in all patients demonstrated an uncertain direction of treatment effect in relation to total SSI (RR 0.98, 95% CI 0.70 to 1.36; I 2 = 0%; very low‐certainty evidence). A single study reported that decolonisation likely results in little to no difference in superficial SSI (RR 1.35, 95% CI 0.84 to 2.15; moderate‐certainty evidence) and a reduction in deep SSI (RR 0.36, 95% CI 0.17 to 0.77; high‐certainty evidence). The evidence on all‐cause mortality from three studies (n = 1564) is very uncertain (RR 0.66, 95% CI 0.24 to 1.84; I 2 = 49%; very low‐certainty evidence). A single study (n = 954) demonstrated that decolonisation may result in little to no difference in hospital readmission for SSI (RR 0.80, 95% CI 0.44 to 1.45; low‐certainty evidence). A single study (n = 954) reported one case of temporary discolouration of teeth in the decolonisation arm (low‐certainty‐evidence. Reoperation for SSI was not reported. Tight glucose control versus standard glucose control Pooled data from seven studies (n = 880) showed that tight glucose control may reduce total SSI, but the evidence is very uncertain (RR 0.41, 95% CI 0.19 to 0.85; I 2 = 29%; numbers need to treat to benefit (NNTB) = 13; very‐low certainty evidence). Pooled data from seven studies (n = 3334) showed tight glucose control may reduce all‐cause mortality, but the evidence is very uncertain (RR 0.61, 95% CI 0.41 to 0.91; I 2 = 0%; very low‐certainty evidence). Based on four studies (n = 2793), there may be little to no difference in episodes of hypoglycaemia between tight control vs. standard control, but the evidence is very uncertain (RR 2.12, 95% CI 0.51 to 8.76; I 2 = 72%; very low‐certainty evidence). No studies reported superficial/deep SSI, reoperation for SSI, or hospital readmission for SSI. Negative pressure wound therapy (NPWT) versus standard dressings NPWT was assessed in two studies (n = 144) and it may reduce total SSI, but the evidence is very uncertain (RR 0.17, 95% CI 0.03 to 0.97; I 2 = 0%; NNTB = 10; very low‐certainty evidence). A single study (n = 80) reported reoperation for SSI. T -Abstract Truncated-

Preventive Strategies In Paediatric Cardiovascular Surgery: Impact On Surgical Site Infections And Beyond

Effectiveness of a program for the reduction of central venous catheter-related bacteremias in a Pediatric Cardiovascular Unit

Healthcare associated infection management in 62 intensive care units for patients with congenital heart disease in China, a survey study

Interventions to prevent surgical site infection in adults undergoing cardiac surgery

Infections Related to Post-Surgery Pediatric Patients of Congenital Cardiopathy in a High Specialty Medical Unit

Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care

Significance of colonization by antibiotic-resistant organisms prior to congenital heart disease surgery in children from low- to middle-income countries sent by non-governmental organizations to Switzerland

Risk factors of ventilator-associated pneumonia in infants and young children after open-heart surgery

The efficacy of nursing interventions in preventing surgical site infections in patients undergoing surgery for congenital heart disease

Association of Previous Cardiac Surgery With Postoperative Pneumonia in Infants Undergoing Abdominal Operations: A Cohort Study

Nosocomial Infections After Pediatric Congenital Heart Disease Surgery: Data from National Center for Cardiovascular Diseases in China

Surgical Urgency, Patient Comorbidities, and Socioeconomic Factors in Surgical Site Infections in Pediatric Surgery

Peri-Operative Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Cardiac and Thoracic Surgery: A RAND/UCLA Appropriateness Method Consensus Study

Prevention of healthcare-associated infections (HAIs) in a surgical urology ward: observational study-analysis of the problem and strategies for implementation

Impact of pulmonary hypertension and congenital heart disease with hemodynamic repercussion on the severity of acute respiratory infections in children under 5 years of age at a pediatric referral center in Colombia, South America

Effects of Preoperative Staphylococcus Aureus Screening and Targeted Decolonization Bundle Protocols in Cardiac Surgery: a Nine-Year Review of a Regional Cardiovascular Center in China

Invasive Bacterial and Fungal Infections After Pediatric Cardiac Surgery: A Single-center Experience

Incidence of infections associated with the use of invasive devices in an ICU after application of the Improvement Science Method

Bloodstream Infections in Infants and Children With Congenital Heart Disease Undergoing Cardiac Surgery

International Nosocomial Infection Control Consortium (INICC) report of healthcare-associated infections, data summary of 25 countries for 2014-2023, Surgical Site Infections Module

Pediatric surgical site infections in 287 hospitals in the United States, 2015–2018